Summary
Highlights
Dr. Ford Brewer discusses his shift from emergency medicine to preventive medicine. He realized that treating acute heart attacks in the ER was a reactive approach and that true patient care lay in prevention. He pursued further education at Johns Hopkins, where he learned about 'denominator medicine' and the importance of looking at population health trends rather than individual cases to understand and prevent disease.
Dr. Brewer shares his personal 'origin story' in preventive medicine. Despite maintaining what he believed was a very healthy lifestyle, including being thin and exercising regularly, a Carotid Intima-Media Thickness (CIMT) scan at age 57 revealed he had arterial plaque. This shocking discovery, after years of practicing prevention, forced him to re-evaluate his understanding of cardiovascular disease and the causes of plaque.
Dr. Brewer emphasizes that while inflammation is a key component of plaque formation, the underlying cause of much of this inflammation is metabolic disease. He points out a significant disconnect in medical practice, where diabetes is known to 'rot arteries' but cholesterol is often the primary focus of treatment. He highlights that over half of adults over 18 have prediabetes, often undiagnosed due to reliance on insuiffient tests like A1C, leading to widespread underestimation of metabolic disease's impact.
The discussion delves into the limitations of the cholesterol hypothesis in explaining heart disease. Dr. Brewer asserts that while 'bad cholesterol' (LDL, apoB) correlates with metabolic disease, it's not the sole or primary cause. He explains that statins, often prescribed to lower cholesterol, offer 'pleiotropic' benefits by reducing inflammation, an effect discovered by doctors like Gavin Blake and Paul Ridker. He only uses statins for a small percentage of patients at very low doses for their anti-inflammatory properties, not solely to lower LDL.
Dr. Brewer corrects the common misconception that cardiovascular disease is solely a heart problem. He stresses that it's a systemic vascular disease affecting arteries throughout the body, including the brain (contributing to dementia), kidneys, and erectile function. He critiques the diagnostic value of calcium scores, explaining that a zero score doesn't rule out plaque as soft, non-calcified plaque can still be present and dangerous.
Dr. Brewer outlines his approach to managing insulin resistance and prediabetes. He prioritizes lifestyle changes over supplements, although he acknowledges the latter's role as a targeted intervention. Key recommendations include reducing visceral fat (aiming for less than 2 lbs) and increasing metabolically active muscle mass (especially in the thighs) through intense exercise, not just walking. He advocates for continuous glucose monitoring (CGMs) to help patients track their blood sugar responses and make informed dietary choices, particularly regarding carbohydrates.
Dr. Brewer describes his patient-centered approach, viewing patients as 'Luke Skywalker' (the hero of their own health journey) and himself as 'Yoda' (a guide providing knowledge and tools). He believes in empowering patients to make informed decisions about their lifestyle, rather than dictating choices. He emphasizes that while he provides the scientific context and tools, the daily implementation of lifestyle changes rests with the individual, leading to better outcomes than a paternalistic approach.
Dr. Brewer expresses excitement about the future of preventive medicine, particularly the integration of AI tools. He reveals a program under development that allows patients to order specific lab tests (beyond what traditional systems often cover) and then plug those results into a specialized AI for interpretation. This AI, distinct from general platforms like ChatGPT, is trained on extensive medical data to provide personalized insights and guidance, promoting patient-centered care and addressing the limitations of direct-to-consumer medicine.